| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA871555 | Functional | Antileishmanial activity against Leishmania donovani LV9 promastigotes by MTT method | Leishmania donovani | 34 | ALA1146876 | organism-based format | Scientific Literature | |
| 2. | ALA871556 | Functional | Antiviral activity against vaccinia virus | Vaccinia virus | 10 | ALA1146876 | organism-based format | Scientific Literature | |
| 3. | ALA871557 | Functional | Antiviral activity against cowpox virus | Cowpox virus | 10 | ALA1146876 | organism-based format | Scientific Literature | |
| 4. | ALA938320 | Functional | Antiviral activity against Vaccinia virus in HFF cells after 1 hr by plaque reduction assay | Vaccinia virus | 8 | ALA1145474 | organism-based format | Scientific Literature | |
| 5. | ALA938321 | Functional | Antiviral activity against Cowpox virus Brighton in HFF cells after 1 hr by plaque reduction assay | Cowpox virus | 8 | ALA1145474 | organism-based format | Scientific Literature | |
| 6. | ALA938322 | Functional | Antiviral activity against TK- Cowpox virus TK:GFP lacZ in HFF cells after 48 hrs by beta-galactosidase assay | Cowpox virus | 8 | ALA1145474 | organism-based format | Scientific Literature | |
| 7. | ALA938323 | Functional | Antiviral activity against TK+ Cowpox virus Delta crmA in HFF cells after 48 hrs by beta-galactosidase assay | Cowpox virus | 8 | ALA1145474 | organism-based format | Scientific Literature | |
| 8. | ALA938324 | Functional | Ratio of EC50 for TK- Cowpox virus TK:GFP lacZ in HFF cells to EC50 for TK+ Cowpox virus delta crmA in HFF cells | Cowpox virus | 8 | ALA1145474 | organism-based format | Scientific Literature | |
| 9. | ALA938325 | ADME | Cytotoxicity against HFF cells after 7 days by CellTiter-Glo assay | Homo sapiens | 8 | ALA1145474 | cell-based format | Scientific Literature | |
| 10. | ALA938326 | Functional | Antiviral activity against TK+ HSV1 E377 in HFF cells after 72 hrs by plaque reduction assay | Human alphaherpesvirus 1 | 7 | ALA1145474 | organism-based format | Scientific Literature | |
| 11. | ALA938327 | Functional | Antiviral activity against TK- HSV1 DM2.1 in HFF cells after 72 hrs by plaque reduction assay | Human alphaherpesvirus 1 | 7 | ALA1145474 | organism-based format | Scientific Literature | |
| 12. | ALA938328 | Functional | Antiviral activity against TK- HSV2 MS in HFF cells after 72 hrs by plaque reduction assay | Human alphaherpesvirus 2 | 7 | ALA1145474 | organism-based format | Scientific Literature | |
| 13. | ALA938329 | Functional | Antiviral activity against TK- HSV2 AG3 in HFF cells after 72 hrs by plaque reduction assay | Human alphaherpesvirus 2 | 7 | ALA1145474 | organism-based format | Scientific Literature | |
| 14. | ALA938330 | Functional | Antiviral activity against Varicella-Zoster virus Ellen in HFF cells after 10 days by plaque reduction assay | Human alphaherpesvirus 3 | 7 | ALA1145474 | organism-based format | Scientific Literature | |
| 15. | ALA938331 | Binding | Activity of Vaccinia virus WR thymidine kinase assessed as ATP utilization by luciferase-based assay | Vaccinia virus | 14 | ALA1145474 | single protein format | Scientific Literature | |
| 16. | ALA938332 | Binding | Ratio of Vmax to Km for Vaccinia virus WR thymidine kinase | Vaccinia virus | 14 | ALA1145474 | single protein format | Scientific Literature | |
| 17. | ALA938333 | Binding | Activity of human thymidine kinase 1 assessed as ATP utilization by luciferase-based assay | Homo sapiens | 14 | ALA1145474 | assay format | Scientific Literature | |
| 18. | ALA938334 | Binding | Ratio of Vmax to Km for human thymidine kinase 1 | Homo sapiens | 14 | ALA1145474 | assay format | Scientific Literature |
The page will load shortly, Thanks for your patience!